Risk of Deaths, AIDS-Defining and Non-AIDS Defining Events among Ghanaians on Long-Term Combination Antiretroviral Therapy

被引:11
|
作者
Sarfo, Fred Stephen [1 ,2 ]
Sarfo, Maame Anima [1 ]
Norman, Betty [1 ]
Phillips, Richard [1 ,2 ]
Bedu-Addo, George [1 ,2 ]
Chadwick, David [3 ]
机构
[1] Komfo Anokye Teaching Hosp, Kumasi, Ghana
[2] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana
[3] James Cook Univ Hosp, Middlesbrough, Cleveland, England
来源
PLOS ONE | 2014年 / 9卷 / 10期
关键词
RECONSTITUTION INFLAMMATORY SYNDROME; HIV-INFECTED ADULTS; CD4 CELL COUNTS; IMMUNE RECONSTITUTION; HIV-1-INFECTED PATIENTS; RENAL DYSFUNCTION; TREATMENT PROGRAM; LOW-INCOME; DISEASE; INDIVIDUALS;
D O I
10.1371/journal.pone.0111400
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Combination antiretroviral therapy (cART) has been widely available in Ghana since 2004. The aim of this cohort study was to assess the incidences of death, AIDS-defining events and non-AIDS defining events and associated risk factors amongst patients initiating cART in a large treatment centre. Clinical and laboratory data were extracted from clinic and hospital case notes for patients initiating cART between 2004 and 2010 and clinical events graded according to recognised definitions for AIDS, non-AIDS events (NADE) and death, with additional events not included in such definitions such as malaria also included. The cumulative incidence of events was calculated using Kaplan Meier analysis, and association of risk factors with events by Cox proportional hazards regression. Data were closed for analysis on 31st December, 2011 after a median follow-up of 30 months (range, 0-90 months). Amongst 4,039 patients starting cART at a median CD4 count of 133 cells/mm(3), there were 324 (8%) confirmed deaths, with an event rate of 28.83 (95% CI 25.78-32.15) deaths per 1000-person follow-up years; the commonest established causes were pulmonary TB and gastroenteritis. There were 681 AIDS-defining events (60.60 [56.14-65.33] per 1000 person years) with pulmonary TB and chronic diarrhoea being the most frequent causes. Forty-one NADEs were recorded (3.64 [2.61-4.95] per 1000 person years), of which hepatic and cardiovascular events were most common. Other common events recorded outside these definitions included malaria (746 events) and respiratory tract infections (666 events). Overall 24% of patients were lost-to-follow-up. Alongside expected risk factors, stavudine use was associated with AIDS [adjusted HR of 1.08 (0.90-1.30)] and death (adjusted HR of 1.60 [1.21-2.11]). Whilst frequency of AIDS and deaths in this cohort were similar to those described in other sub-Saharan African cohorts, rates of NADEs were lower and far exceeded by events such as malaria and respiratory tract infections.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Incidence and spectrum of AIDS-defining illnesses among persons treated with antiretroviral drugs
    Michaels, SH
    Clark, R
    Kissinger, P
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) : 468 - 469
  • [22] HIV Prevalence and Characteristics Among Patients With AIDS-Defining and Non-AIDS-Defining Cancers in a Tertiary Hospital in Kenya
    Muturi, Diana
    Mwanzi, Sitna N.
    Riunga, Felix M.
    Shah, Jasmit
    Shah, Reena
    [J]. JCO GLOBAL ONCOLOGY, 2023, 9 : e2200360
  • [23] Long-term trends in mortality and AIDS-defining events among perinatally HIV-infected children across Europe and Thailand
    Judd, A.
    Chappell, E.
    Doerholt, K.
    Galli, L.
    Giaquinto, C.
    Gibb, D.
    Goetghebuer, T.
    Le Coeur, S.
    Julian, A. Noguera
    Turkova, A.
    Goodall, R.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [24] Reduced economic burden of AIDS-defining illnesses associated with adherence to antiretroviral therapy
    Toh, Han-Siong
    Yang, Chun-Ting
    Yang, Kai-Li
    Ku, Han-Chang
    Liao, Chia-Te
    Kuo, Shihchen
    Tang, Hung-Jen
    Ko, Wen-Chien
    Ou, Huang-Tz
    Ko, Nai-Ying
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 91 : 44 - 49
  • [25] Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological Conditions
    Caniglia, Ellen C.
    Phillips, Andrew
    Porter, Kholoud
    Sabin, Caroline A.
    Winston, Alan
    Logan, Roger
    Gill, John
    Vandenhende, Marie-Anne
    Barger, Diana
    Lodi, Sara
    Moreno, Santiago
    Ramon Arribas, Jose
    Pacheco, Antonio
    Cardoso, Sandra W.
    Chrysos, George
    Gogos, Charalabos
    Abgrall, Sophie
    Costagliola, Dominique
    Meyer, Laurence
    Seng, Remonie
    van Sighem, Ard
    Reiss, Peter
    Muga, Roberto
    Perez Hoyos, Santiago
    Braun, Dominique
    Hauser, Christoph
    Barrufet, Pilar
    Leyes, Maria
    Tate, Janet
    Justice, Amy
    Hernan, Miguel A.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2018, 77 (01) : 102 - 109
  • [26] Effect of highly active antiretroviral therapy on multiple AIDS-defining illnesses among male HIV seroconverters
    Cain, LE
    Cole, SR
    Chmiel, JS
    Margolick, JB
    Rinaldo, CR
    Detels, R
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (04) : 310 - 315
  • [27] Predictors of AIDS-defining events among advanced naive patients after HAART
    Torti, Carlo
    Lapadula, Giuseppe
    Maggiolo, Franco
    Casari, Salvatore
    Suter, Fredy
    Minoli, Lorenzo
    Pezzoli, Chiara
    Di Pietro, Massimo
    Migliorino, Guglielmo
    Quiros-Roldan, Eugenia
    Ladisa, Nicoletta
    Sighinolfi, Laura
    Gatti, Francesca
    Carosi, Giampiero
    [J]. HIV CLINICAL TRIALS, 2007, 8 (03): : 112 - 120
  • [28] The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS
    Hessol, Nancy A.
    Pipkin, Sharon
    Schwarcz, Sandra
    Cress, Rosemary D.
    Bacchetti, Peter
    Scheer, Susan
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2007, 165 (10) : 1143 - 1153
  • [29] Non-AIDS defining malignancies among HIV-infected patients
    Anejo-Okopi, Joseph
    Onywera, Harris
    Omale, Simeon
    Audu, Onyemocho
    [J]. HIV & AIDS REVIEW, 2021, 20 (03): : 151 - 157
  • [30] Immune restoration and onset of new AIDS-defining events with combination antiretroviral therapy in HIV type-1-infected immigrants in the Netherlands
    Kesselring, Anouk M.
    Gras, Luuk
    Wit, Ferdinand W.
    Smit, Colette
    Geerlings, Suzanne E.
    Mulder, Jan W.
    Schreij, Gerrit
    Sprenger, Herman
    Reiss, Peter
    de Wolf, Frank
    [J]. ANTIVIRAL THERAPY, 2010, 15 (06) : 871 - 879